Antiplatelet effect of Mirtazapine via co–blocking 5–HT2A receptor and α2–adrenergic receptor on platelet –In vitro human plasma–based study–

○Maki Obana

[29P01-299S] Antiplatelet effect of Mirtazapine via co–blocking 5–HT_2A receptor and α₂–adrenergic receptor on platelet –In vitro human plasma–based study–

○Maki Obana¹, Maho Katsuyama¹, Yohei Kawano¹, Masamichi Takagi², Takao Aoyama¹ (1. Grad. Sch. Pharm. Sci., Tokyo Univ. Science., 2. The Jikei University School of Medicine, Kashiwa Hospital.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[29P01] 薬物療法（基礎）

[29P01-299S] Antiplatelet effect of Mirtazapine via co–blocking 5–HT_2A receptor and α₂–adrenergic receptor on platelet –In vitro human plasma–based study–

Password

Presentation information

[29P01] 薬物療法（基礎）

[29P01-299S] Antiplatelet effect of Mirtazapine via co–blocking 5–HT2A receptor and α2–adrenergic receptor on platelet –In vitro human plasma–based study–

Password

[29P01-299S] Antiplatelet effect of Mirtazapine via co–blocking 5–HT_2A receptor and α₂–adrenergic receptor on platelet –In vitro human plasma–based study–